Loading...

Renascience Inc.

4889.TJPX
Healthcare
Biotechnology
¥2916.00
¥13.00(0.45%)

Renascience Inc. (4889.T) Stock Competitors & Peer Comparison

See (4889.T) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
4889.T¥2,916.00+0.45%35.4B309.44¥9.00N/A
4587.T¥1,691.00+1.32%217.8B14.77¥114.16N/A
4592.T¥2,450.00+4.93%179.7B-40.82-¥61.12N/A
2160.T¥2,948.00+3.80%147.7B-163.46-¥17.87N/A
4974.T¥922.00+1.77%110.3B106.39¥8.61+1.86%
4565.T¥887.00-3.69%85.2B-36.71-¥25.66N/A
4593.T¥637.00+2.41%70.6B-14.17-¥45.53N/A
4894.T¥6,140.00+0.66%50.4B-76.25-¥80.52N/A
4563.T¥70.00-5.41%25.1B-0.62-¥114.38N/A
7774.T¥576.00-1.87%23.6B-92.37-¥6.29N/A
Showing 1 to 10 of 45 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

4889.T vs 4587.T Comparison August 2025

4889.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4889.T stands at 35.4B. In comparison, 4587.T has a market cap of 217.8B. Regarding current trading prices, 4889.T is priced at ¥2,916.00, while 4587.T trades at ¥1,691.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4889.T currently has a P/E ratio of 309.44, whereas 4587.T's P/E ratio is 14.77. In terms of profitability, 4889.T's ROE is +0.07%, compared to 4587.T's ROE of +0.26%. Regarding short-term risk, 4889.T is more volatile compared to 4587.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4889.T.Check 4587.T's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;